Epigral's stock price fell after the company announced it received an income tax demand notice for Rs 52.52 crore for the Assessment Year 2022-23. The company stated it has grounds to contest the demand, asserting no immediate financial impact and plans to file a rectification application and appeal. Epigral, a significant chemical manufacturer, previously reported a 36% drop in net profit for Q2 FY26.